GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $11.4M invested in Galmed Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

0.01% more ownership

Funds ownership: 0.05% → 0.06% (+0.01%)

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$685K
2
+$537K
3
+$451K
4
Morgan Stanley
Morgan Stanley
New York
+$232K
5
LNWWM
Laird Norton Wetherby Wealth Management
California
+$91K

Top Sellers

1
-$138K
2
-$48K
3
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.02M
2
$2.56M
3
$1.36M
4
$1.11M
5
$960K
6
$167K
7
$108K
8
$91K
9
$57K
10
$5K
11
$2K
12
–
13
–